| Stem definition | Drug id | CAS RN |
|---|---|---|
| humanized origin | 4959 | 214745-43-4 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
a humanized anti-CD11anti-adhesion monoclonal antibody
|
| Dose | Unit | Route |
|---|---|---|
| 10 | mg | P |
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Sept. 20, 2004 | EMA | ||
| Oct. 27, 2003 | FDA | GENENTECH |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Psoriasis | 80.67 | 75.13 | 26 | 306 | 86931 | 63401759 |
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | L04AA21 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS Selective immunosuppressants |
| FDA CS | M0001357 | Antibodies, Monoclonal |
| FDA MoA | N0000175856 | CD11a-directed Antibody Interactions |
| FDA EPC | N0000175858 | CD11a-directed Humanized IgG1 Antibody |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Plaque psoriasis | indication | 200965009 |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Leukocyte adhesion glycoprotein LFA-1 alpha | Adhesion | ANTIBODY BINDING | Kd | 11.40 | IUPHAR | DRUG LABEL |
| ID | Source |
|---|---|
| D03959 | KEGG_DRUG |
| 4021411 | VUID |
| N0000148826 | NUI |
| 4021411 | VANDF |
| CHEMBL1201575 | ChEMBL_ID |
| C472181 | MESH_SUPPLEMENTAL_RECORD_UI |
| 6593 | IUPHAR_LIGAND_ID |
| DB00095 | DRUGBANK_ID |
| 356988 | RXNORM |
| 17649 | MMSL |
| 47678 | MMSL |
| d04902 | MMSL |
| 005208 | NDDF |
| 407005009 | SNOMEDCT_US |
| 407006005 | SNOMEDCT_US |
| C1174995 | UMLSCUI |
| 8122 | INN_ID |
| XX2MN88N5D | UNII |
None